Free Trial

Apellis Pharmaceuticals (APLS) SEC Filings & 10K Form

Apellis Pharmaceuticals logo
$19.44 -0.09 (-0.46%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$19.31 -0.13 (-0.67%)
As of 07/11/2025 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Apellis Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/01/2025
6:09 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:49 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
9:38 AM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
3:10 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:15 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025
10:46 AM
Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
10:44 AM
Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2025
12:19 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
3:42 PM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SCHEDULE 13G
05/12/2025
1:22 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:01 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
6:33 AM
Apellis Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
6:35 AM
Apellis Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
6:36 AM
Apellis Pharmaceuticals (Filer)
Form ARS
04/21/2025
3:23 PM
Apellis Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
6:11 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
11:27 AM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
2:18 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
6:22 AM
Apellis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
6:00 AM
Apellis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
12:59 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:13 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:49 AM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/03/2025
12:09 PM
Apellis Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G
01/30/2025
11:13 AM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:15 AM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:18 AM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:20 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:01 AM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:03 AM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:07 AM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:10 AM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:12 AM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
2:42 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:18 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:22 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:26 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:11 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:12 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:16 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
01/29/2025
2:16 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:17 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
2:37 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:39 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:41 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:23 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:25 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:26 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:28 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:29 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:31 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:19 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:00 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:39 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:42 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:43 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:44 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:45 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:45 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:51 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:52 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:56 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
2:56 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
2:59 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
2:54 PM
Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:38 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:20 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:27 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:29 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:22 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:25 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:29 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:30 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:09 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:10 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:14 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:15 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:55 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
4:56 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:00 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:02 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:02 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:05 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:07 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:09 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:13 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:15 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
8:08 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:38 PM
Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2025
4:39 PM
Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
01/08/2025
3:03 PM
Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
2:17 PM
Apellis Pharmaceuticals (Subject)
Baumal Caroline (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
3:06 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:48 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:16 PM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/22/2024
7:47 AM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G
11/08/2024
4:31 PM
Apellis Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/08/2024
9:52 AM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APLS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners